EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nicolas Garel: Combining psychoactive molecules and psychotherapy for patients suffering from mood and substance use disorders: a new therapeutic paradigm

Nicolas Garel

Psychedelics · 2024

DOI: 10.61373/pp024k.0016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychedelics, 2024. Verfasst von Nicolas Garel. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dr Nicolas Garel is an Assistant Professor in the Department of Psychiatry and Addictology at the University of Montreal and a junior investigator at the Research Center of the Centre Hospitalier de l'Université de Montréal. Dr Garel did his psychiatry residency at McGill University before completing the Clinician-Investigator Program and a Master's degree at McGill University, studying the potential role of ketamine in the discontinuation of benzodiazepines and related drugs. Dr Garel then completed a clinical fellowship in Addiction Medicine at Stanford University. His research program focuses on the integration of psychoactive molecules in conjunction with psychotherapy as a unique potential treatment approach for patients with comorbid mood and alcohol/sedative use disorders. In this “Innovators & Ideas” section, we are excited to feature Dr Garel in our latest Genomic Press Interview. We are thrilled he took the time to answer our questions and share his valuable insights with our readers.

Zitieren

APA

Garel, N. (2024). Nicolas Garel: Combining psychoactive molecules and psychotherapy for patients suffering from mood and substance use disorders: a new therapeutic paradigm. Psychedelics. https://doi.org/10.61373/pp024k.0016

Vancouver

Garel N. Nicolas Garel: Combining psychoactive molecules and psychotherapy for patients suffering from mood and substance use disorders: a new therapeutic paradigm. Psychedelics. 2024. doi:10.61373/pp024k.0016

BibTeX
@article{Garel2024,
  author = {Garel, Nicolas},
  title = {Nicolas Garel: Combining psychoactive molecules and psychotherapy for patients suffering from mood and substance use disorders: a new therapeutic paradigm},
  journal = {Psychedelics},
  year = {2024},
  doi = {10.61373/pp024k.0016}
}
Kostenlos starten →